#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA976243	B	Inhibition of bovine alpha-chymotrypsin assessed as association equilibrium constant	Bos taurus	13		single protein format	Scientific Literature
2.	ALA976244	B	Inhibition of cathepsin G assessed as association equilibrium constant		13		single protein format	Scientific Literature
3.	ALA976245	B	Inhibition of cathepsin G assessed as association equilibrium constant relative to [Phe5]SFTI-1		5		single protein format	Scientific Literature
4.	ALA976246	B	Inhibition of cathepsin G		1		single protein format	Scientific Literature
5.	ALA976247	B	Inhibition of cathepsin G using association equilibrium constant assay		1		single protein format	Scientific Literature
6.	ALA954099	A	Proteolytic stability assessed as half life of trypsin-mediated hydrolysis by RP-HPLC		8		assay format	Scientific Literature
7.	ALA954100	B	Inhibition of bovine beta trypsin assessed as residual activity by spectrophotometry	Bos taurus	6		single protein format	Scientific Literature
8.	ALA954101	B	Inhibition of bovine alpha chymotrypsin assessed as residual activity by spectrophotometry	Bos taurus	5		assay format	Scientific Literature
9.	ALA1292371	B	Inhibition of bovine trypsin	Bos taurus	9		assay format	Scientific Literature
10.	ALA1292372	B	Inhibition of bovine chymotrypsin	Bos taurus	12		assay format	Scientific Literature
11.	ALA2445843	F	Antiasthmatic activity in OVA-immunized BALB/c mouse chronic asthma model assessed as reduction of 8-isoprostane level in serum at 10 uM treated intranasally by immunoassay	Mus musculus	2		organism-based format	Scientific Literature
12.	ALA2445845	F	Antiasthmatic activity in OVA-immunized BALB/c mouse chronic asthma model assessed as plasma histamine release at 0.1 uM treated intranasally after 5 mins by immunoassay	Mus musculus	2		organism-based format	Scientific Literature
13.	ALA2445846	F	Antiasthmatic activity in OVA-immunized BALB/c mouse chronic asthma model assessed as inhibition of tryptase-like protease activity in BAL fluid using tosyl-gly pros-lys-pNA as substrate at 100 nM after 1 hr relative to control	Mus musculus	2		organism-based format	Scientific Literature
14.	ALA2445847	F	Antiasthmatic activity in OVA-immunized BALB/c mouse chronic asthma model assessed as inhibition of tryptase-like protease activity in BAL fluid using tosyl-gly pros-lys-pNA as substrate after 1 hr	Mus musculus	2		organism-based format	Scientific Literature
15.	ALA2445848	F	Antiasthmatic activity in OVA-immunized BALB/c mouse chronic asthma model assessed as inhibition of airway remodeling at 100 nM treated intranasally on days 15, 16, 22, and 23 at 30 mins before OVA challenge measured on day 71	Mus musculus	2		organism-based format	Scientific Literature
16.	ALA2445849	F	Antiasthmatic activity in OVA-immunized BALB/c mouse chronic asthma model assessed as reduction of area of proliferating smooth muscle cell at 100 nM treated intranasally on days 15, 16, 22, and 23 at 30 mins before OVA challenge measured on day 71 by PCNA+-staining	Mus musculus	2		organism-based format	Scientific Literature
17.	ALA2445850	F	Antiasthmatic activity in OVA-immunized BALB/c mouse chronic asthma model assessed as reduction of decrease in smooth muscle area at 100 nM treated intranasally on days 15, 16, 22, and 23 at 30 mins before OVA challenge measured on day 71 by alpha-SMA-staining	Mus musculus	2		organism-based format	Scientific Literature
18.	ALA2445851	F	Antiasthmatic activity in OVA-immunized BALB/c mouse chronic asthma model assessed as reduction of collagen and old fibrin at 100 nM treated intranasally on days 15, 16, 22, and 23 at 30 mins before OVA challenge measured on day 71 by martius scarlet blue-staining	Mus musculus	2		organism-based format	Scientific Literature
19.	ALA2445852	F	Antiasthmatic activity in OVA-immunized BALB/c mouse chronic asthma model assessed as reduction of methacholine-induced airway hyperreactivity at 100 nM treated intranasally on days 15, 16, 22, and 23 at 30 mins before OVA challenge measured on day 71	Mus musculus	2		organism-based format	Scientific Literature
20.	ALA2445853	F	Antiasthmatic activity in OVA-immunized BALB/c mouse chronic asthma model assessed as reduction of airway inflammation at 100 nM treated intranasally on days 15, 16, 22, and 23 at 30 mins before OVA challenge by hematoxylin and eosin staining measured on day 71	Mus musculus	2		organism-based format	Scientific Literature